‘Critical Step’ For Petros Toward ED Switch Proposal With OTC Label Comprehension Study

Petros Pharmaceuticals anticipates Drug Facts label technology it’s developing for potential switch of its Stendra ED drug also could be used for other OTC switch proposals. • Source: Petros Pharmaceuticals
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Rx-to-OTC Switch

More from Health